US Patent 10544221 Single chain variable fragment CD3 binding proteins
Patent 10544221 was granted and assigned to Harpoon Therapeutics on January, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10544221 Single chain variable fragment CD3 binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.